Matthew A. Nugent - Concepedia

Author

Matthew A. Nugent

Also Known As

M A Nugent, M. A. Nugent, M. Nugent, M.A. Nugent, MATTHEW A NUGENT, MATTHEW NUGENT, Matthew A Nugent, Matthew A. NUGENT, Matthew A. Nugent, Matthew Nugent

144

Publications

6.8K

Citations

H-Index

131

Concepts

All Affiliations

Boston University University of Massachusetts Lowell Massachusetts Institute of Technology Virginia Tech Harvard–MIT Division of Health Sciences and Technology

About

Matthew A. Nugent is an author at Boston University specializing in medicine, cell biology, and extracellular matrix.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	52	3.1K
2	Engineering	14	15	1K
3	Natural Sciences	8	8	338
4	Health Sciences	4	4	388
5	Allergy	1	1	22

Matthew A. Nugent

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Mechanisms of Venous Leakage: A Prospective Clinicopathological Correlation of Corporeal Function and Structure Ajay Nehra, Irwin Goldstein, Ajay Pabby, The Journal of Urology	1996	272
Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Elazer R. Edelman, Matthew A. Nugent, Morris J. Karnovsky Proceedings of the National Academy of Sciences Tissue EngineeringEngineeringIntravenous AdministrationPathologyBiomedical Engineering	1993	265
Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. Elazer R. Edelman, Matthew A. Nugent, Lynne T. Smith, Journal of Clinical Investigation Vasa VasorumPathologyCell ProliferationBiomedical EngineeringRegenerative Medicine	1992	243
Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativity Matthew A. Nugent, Elazer R. Edelman Biochemistry	1992	235
Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin György Csordás, Manoranjan Santra, Charles C. Reed, Journal of Biological Chemistry	2000	217
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. Bela Sharma, Melissa Handler, Inge Eichstetter, Journal of Clinical Investigation Perlecan Gene ExpressionAngiogenesisNanotherapeuticsMedicineTumor Growth	1998	191
Heparan Sulfate Mediates bFGF Transport through Basement Membrane by Diffusion with Rapid Reversible Binding Christopher J. Dowd, Charles L. Cooney, Matthew A. Nugent Journal of Biological Chemistry	1999	168
Potentiation and Inhibition of bFGF Binding by Heparin: A Model for Regulation of Cellular Response Michael Fannon, Kimberly E. Forsten, Matthew A. Nugent Biochemistry	2000	147
Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia Matthew A. Nugent, Helen M. Nugent, Renato V. Iozzo, Proceedings of the National Academy of Sciences Tissue EngineeringVascular DiseaseEngineeringEndothelial CellsImmunology	2000	138
Heparan sulfate–FGF10 interactions during lung morphogenesis Konstantin I. Izvolsky, Deana Shoykhet, Yang Yu, Developmental Biology Developmental BiologyLung InflammationMedicineFibroblast Growth FactorMatrix Biology	2003	128

Page 1